Home  »  Ipo Review  »  Supriya Lifescience Ipo

Let’s have a detailed review of the company and analytics of the Supriya Lifescience IPO release date, IPO offer price, subscription, Supriya Lifescience Limited IPO allotment, grey market price, and other details like the company’s background, its financial positions, its promoters, and other related things.

Face ValueRs 2
Cash PriceRs 265 to Rs 274
Listing AtBSE, NSE
Min. Order Quantity54 Shares
Listing DateDec 28, 2021
Offer for SaleRs 5000 Million
Fresh IssueRs 2,000 Million
IPO SizeRs 7000 Million
Tick Size1

Supriya Lifescience IPO is listed at a [●] premium. Check out the live share price by clicking on the below link.


Supriya Lifescience IPO – Summary

Supriya Lifescience IPOThey are one of the key Indian manufacturers and suppliers of active pharmaceuticals ingredients (“APIs”), with a focus on research and development. As of March 31, 2021, they have niche product offerings of 39 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anesthetic, vitamin, anti-asthmatic and anti-allergic.

They have consistently been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India, contributing to 45-55% and 65-70%, respectively, of the API exports from India, between Fiscal 2017 and 2020. They were among the largest exporters of Salbutamol Sulphate from India in Fiscal 2020 in terms of volume

The Promoter of this company is SATISH WAMAN WAGH. The lead manager to the issue is ICICI Securities Limited, and Axis Capital Limited, and the Registrar to this issue is Link Intime India Private Limited.


Supriya Lifescience IPO Date

The opening and the closing date of the IPO of Supriya Lifescience Limited are Dec 16, 2021, and Dec 20, 2021, respectively.

Check out Related IPO Links:

Supriya Lifescience IPO GMP
Supriya Lifescience IPO Allotment

Supriya Lifescience IPO Subscription

Day / DateQIBNIIRIITotal Subscription
1st Day – 16th Dec0.00x0.66x11.84x2.33x
2nd Day –  17th Dec0.53x2.90x25.38x5.69x
3rd Day – 20th Dec31.83x161.22x55.75x71.47x
Shares Offered or Net Issue7,924,5273,962,2632,641,50914,528,299

The shares subscribed by the public will be updated here.

Check Supriya Lifescience IPO LIVE Subscription

  • Supriya Lifescience IPO LIVE Bid details on BSE
  • Supriya Lifescience IPO LIVE Bid details on NSE

For the Latest Bid details click on the above links.


Supriya Lifescience IPO Allotment Status

Here, you can find the Allotment Status of this IPO.

Allotment of Equity Shares pursuant to the Fresh Issue and transfer of the Offered Shares of the Promoter Selling Shareholders pursuant to the Offer for Sale to the successful Bidders. However, the Allotment Status is not yet disclosed.

Supriya Lifescience Limited IPO Listing Date

Find the dates below on basis of allotment, refund, listing, and more:

Basis of Allotment FinalizationDec 23, 2021
Refunds InitiationDec 24, 2021
Credit of Shares to Demat AccountDec 27, 2021
Share Listing DateDec 28, 2021

Supriya Lifescience IPO Cash Price

The face value of each share is Rs.2, but the price band of the IPO is Rs 265 to Rs 274 


Supriya Lifescience IPO Equity Size

This Initial Public Issue of X Equity Shares of Rs.2 each for cash at a price of Rs 265 to Rs 274 per equity share aggregating to Rs.7000 Million.


Supriya Lifescience IPO Share Offering

Fresh Issue: The Issue (excluding the Market Maker Reservation Portion) of [●] Equity Shares of Rs.2/ each.

Issue Size: X Equity Shares of Rs.2 each, aggregating to Rs.7000 Million

Offer for Sale Size: X Equity Shares of Rs.2 each, aggregating to Rs.5,000 Million


Open Free Demat Account Now!

    Fill Your Details Here


    Supriya Lifescience IPO – Live Performance

    The listing date of this IPO is Dec 28, 2021. You can check the live performance of the IPO here, only after it is listed on exchanges.

    Live IPO Performance – Supriya Lifescience Share Price

    Supriya Lifescience IPO Grey Market Premium

    The Supriya Lifescience Limited IPO Grey Market Premium price is Rs 140, the Kostak rate is Rs NA and the Subject to Sauda is Rs 6000. 


    Supriya Lifescience IPO – Company Overview

    Their pharmaceutical business is organized into domestic and export sales, according to the geographies in which they operate. In Fiscal 2021, their products were exported to 78 countries to 1,060 customers including 286 distributors.

    Their customers include global pharma companies such as Syntec Do Brasil LTDA, American International Chemical Inc, and AT Planejamento E Desenvolvimento De Negocios Ltda, with whom they have a business relationship for over nine years, and Suan Farma Inc, Acme Generics LLP, Akum Drugs Ltd and Mankind Pharma Ltd with whom they have a business relationship for over four years.

    Their products are approved by various international regulatory authorities such as USFDA, EUGMP, EDQM, SFDA NMPA, ANVISA, KFDA, PMDA, TGA, and Taiwan FDA. As of March 31, 2021, they have filed 11 active DMFs with USFDA and seven active CEPs with EDQM, for their API products in therapeutic areas such as antihistamine, analgesic, anesthetic, vitamin, anti-asthmatic and anti-allergic.


    Supriya Lifescience IPO – Financial Statements

    A quick look into the past financial performance of the company to understand its performance of the business and evaluate the growth prospectus:

    Financial Summary:

    Amount (in INR & Million)
    30-Sep-2031-Mar-21Mar-2031-Mar-19
    Total Assets5,041.024,458.243,364.012,530.52
    *Total Revenue2,300.613,962.213,227.132,858.62
    Total Expense1,313.942,180.702,132.622,131.01
    Profit After Tax659.591,238.28733.74394.24

    Earnings per Equity Share (in Million)

    30-Sep-2031-Mar-21Mar-2031-Mar-19
    Basic & Diluted9.01
    16.92
    10.035.39

    Supriya Lifescience IPO – Promoters

    The Promoter of this company is:

    1. SATISH WAMAN WAGH

    List of Related Parties (Key Managerial Personnel)

    • Satish Waman Wagh, Chairman and Managing Director
    • Smita Satish Wagh, Whole-time Director
    • Saloni Satish Wagh, Whole-time Director
    • Shivani Satish Wagh, Whole-time Director
    • Balasaheb Gulabrao Sawant, Whole-time Director
    • Kedar Shankar Karmarkar, Independent Director

    Supriya Lifescience IPO – Promoters Holding

    • Pre Issue Share Holding – 99.98%
    • Post Issue Share Holding – %

    Supriya Lifescience IPO Offer Details or Issue Details

     Particulars No. Of Equity Shares
     Equity Shares Offered Up to X Equity Shares aggregating up to Rs.7000 Million
    of which:
    Issue Reserved for the Market MakersUp to [●] Equity Shares aggregating up to Rs.2,000 Million
    Net Issue to the PublicUp to [●] Equity Shares aggregating up to Rs.5,000 Million
    Of which:
    Retail Investors Portion Not less than [●] Equity Shares
    Other than Retail Individual InvestorsNot more than [●] Equity Shares
     Equity Shares outstanding prior to the Issue73,183,530 Equity Shares
     Equity Shares outstanding after the Issue73,183,530 Equity Shares

    Supriya Lifescience IPO Issue Object

    Their Company proposes to utilize the Net Proceeds towards funding the following objects:

    1. Funding capital expenditure requirements of their Company
    2. Repayment and/ or pre-payment, in full or part, of certain borrowings availed by their Company
    3. General corporate purposes

    Supriya Lifescience IPO – Business Strategy

    • Expansion of manufacturing capabilities
    • Expanding product portfolio with increasing R&D capabilities
    • Increase current market presence and enter new markets
    • Continue to focus on operational excellence

    Supriya Lifescience IPO – Basis of Offer Price

    The issue price is determined by the company in consultation with the Lead manager on the basis of the following qualitative and quantitative factors.

    Qualitative factors are:

    • Significant scale with a leadership position across key & niche products
    • Backward integrated business model
    • Advanced manufacturing and research and development capabilities
    • Consistent strong financial performance due to de-risked business model
    • Experienced senior management team and qualified operational personnel

    The relevant quantitative factors are:

    Basic & Diluted EPSRONW (%)NAV (Rs.)
    31-Mar-2010.0349.1920.38
    31-Mar-195.3942.03
    Mar-181.1915.97

    Supriya Lifescience IPO: Competitive Peers

    Face Value (Rs.)P/EEPS  (Rs.)Return on Net Worth (%)Total Income (Rs. in Millions)
    Supriya Lifescience Limited2NA10.4133.852,679.27
    Listed Peers
    Solara Active Pharma Sciences Limited1035.3444.2910.5013,492.70
    Neuland Laboratories Limited 10212.4212.632.287,665.97
    Aarti Drugs Limited1012.8960.5721.6718,075.71
    Wanbury Limited103.9526.90(44.94) 3,685.95
    Divis Laboratories Limited277.7151.8518.8355,840.50

    Supriya Lifescience IPO Lead Managers

    Lead Managers
    ICICI Securities Limited

    Axis Capital Limited

    Supriya Lifescience IPO Registrar to offer

    Registrar to the Offer
    Link Intime India Private Limited
    C-101, 247 Park, 1st Floor,
    L.B.S. Marg, Vikhroli West
    Mumbai 400 083
    Maharashtra. India
    Tel: +91 22 4918 6200
    E-mail: supriyalife.ipo@linkintime.co.in
    Website: www.linkintime.co.in
    Contact Person: Shanti Gopalkrishnan
    SEBI Registration No.: INR000004058

    Supriya Lifescience IPO – Other Details

    • Statutory Auditor – Kakaria and Associates LLP, Chartered Accountants
    • Legal Counsel to the Company – Khaitan & Co
    • Bankers to the Company –  NA


    Supriya Lifescience IPO Review by Stock Brokers

    Top Stock Brokers ReviewCompany ReputationCompetitive EdgeFinancial StatementPopularity IndexPromoters Reputation
    Angel Broking7.5/107.4/108.5/108.1/107.1/10
    Sharekhan7.2/107.1/108.6/108.1/107.2/10
    Kotak Securities7.3/107.5/108.4/108.1/107.3/10
    ICICI Direct7.3/107.3/108.7/108.1/107.1/10
    IIFL7.5/107.2/108.8/108.0/107.1/10
    Edelweiss7.5/107.4/108.4/108.3/107.2/10
    Zerodha7.4/107.1/108.5/108.1/107.0/10
    5Paisa7.1/107.1/108.4/108.1/107.1/10
    Karvy7.4/107.3/108.2/108.1/107.1/10
    Motilal Oswal7.1/107.1/108.6/108.3/107.2/10

     


    Subscribe to Supriya Lifescience IPO

      Fill Your Details Here


      Supriya Lifescience Limited IPO News

      News 1 – IPO DRHP Download

      News 2 – IPO RHP Prospectus Download


      Supriya Lifescience IPO Review FAQs

      Ques – What is the Issue Size of Supriya Lifescience IPO?

      Answer – The Company is making an initial public offer of NA equity shares. They vividly portray the aspects of the issue in this article. You can check the stats on the fresh issue, Offer for sale, and net issue.

      Ques – What is the Price band of Supriya Lifescience IPO?

      Answer – The price band for this particular IPO ranges between Rs 265 to Rs 274. As far as the face value of the share is of concern, it is Rs.2 per share.

      Ques – What is the Supriya Lifescience IPO Open Date?

      Answer – The opening and closing dates for this IPO have been updated. The IPO is set to open on Dec 16, 2021, while the closing date is set at Dec 20, 2021.

      Ques – What is the Supriya Lifescience IPO Allotment Date?

      Answer – They also have the news regarding the respective allotment dates of this IPO. Basis of Allotment finalization is on Dec 23, 2021, refund initiation is on Dec 24, 2021, credit of shares is on Dec 27, 2021, and share listing date is on Dec 28, 2021.

      Ques – What is the Supriya Lifescience IPO Listing Date?

      Answer – Shares of this company shall be listed in the exchanges on Dec 28, 2021. The date, when the listing would be done, is stagnant on Dec 28, 2021.

      Ques – Who is the Registrar of Supriya Lifescience IPO?

      Answer – One of the reputed registrars is managing the issue of this IPO, i.e. Link Intime India Private Limited. Their website will help you regarding the further information you are on the lookout for.

      Ques – Who is the Promoter of Supriya IPO?

      Answer – Here are the promoters of this IPO – SATISH WAMAN WAGH. You can refer to the RHP for further information on the promoter. You will find the link to RHP in the article.

      Ques – What is the GMP of Supriya Lifescience IPO?

      Answer – They have obtained the GMP of this IPO and it is Rs 140. Further insights of Kostak rate and subject to sauda or SS are as well included in this report.

      Ques – Is Supriya IPO good for Investment?

      Answer – They have further provided the financial status of the company in this article, from the past few years. You can refer to the same, and also check the line of operations they are into and then decide to invest in the IPO.

      Ques – What is the PAT of Supriya Lifescience Ltd?

      Answer – They have the information of company financials, and according to that, they have the figures from the last few years to provide. PAT for the financial year 2021 in Million is 1,238.28, 2020 is 733.74, 2019 is 394.24. PAT from Sep 2021 is 659.59.


      Calculate your return on investment!


      Asset ClassROI (Rs.)Profit (Rs.)Profit (%)
      IPO
      Equity
      Savings
      Real Estate
      Gold
      Bonds
      Fixed Deposit
      Mutual Fund


      Featured Topics

       

      Leave a Reply

      Your email address will not be published.

      24 + 9 =

      Get 100% IPO Allotment Guarantee! Subscribe to IPO